IL37 and pancreatic neoplasm: Furthermore, it has been reported that interleukin-37 (IL-37) suppressed hypoxia-inducible factor-1α (HIF-1α) expression through STAT3 inhibition during the progression and chemoresistance of pancreatic cancer [17].